Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks.

In an effort to find gene regulatory networks and clusters of genes that affect cancer susceptibility to anticancer agents, we joined a database with baseline expression levels of 7,245 genes measured by using microarrays in 60 cancer cell lines, to a database with the amounts of 5,084 anticancer agents needed to inhibit growth of those same cell lines. Comprehensive pair-wise correlations were calculated between gene expression and measures of agent susceptibility. Associations weaker than a threshold strength were removed, leaving networks of highly correlated genes and agents called relevance networks. Hypotheses for potential single-gene determinants of anticancer agent susceptibility were constructed. The effect of random chance in the large number of calculations performed was empirically determined by repeated random permutation testing; only associations stronger than those seen in multiply permuted data were used in clustering. We discuss the advantages of this methodology over alternative approaches, such as phylogenetic-type tree clustering and self-organizing maps.

[1]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[2]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[3]  P M Steinert,et al.  Molecular and cellular biology of intermediate filaments. , 1988, Annual review of biochemistry.

[4]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[5]  D. Kulesh,et al.  Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8 , 1989, Molecular and cellular biology.

[6]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[7]  J N Weinstein,et al.  Neural computing in cancer drug development: predicting mechanism of action. , 1992, Science.

[8]  AC Tose.  Cell , 1993, Cell.

[9]  J N Weinstein,et al.  Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents. , 1994, Journal of the National Cancer Institute.

[10]  J. Leavitt,et al.  Activation of the leukocyte plastin gene occurs in most human cancer cells. , 1994, Cancer research.

[11]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[12]  D. Johnston,et al.  Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastin. , 1996, Cancer Research.

[13]  M. Kuwano,et al.  Increased expression of T‐plastin gene in cisplatin‐resistant human cancer cells: identification by mRNA differential display , 1996, FEBS letters.

[14]  R. Cote,et al.  Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues. , 1997, The American journal of pathology.

[15]  C. Mitchell,et al.  Activation of the 43 kDa inositol polyphosphate 5-phosphatase by 14-3-3zeta. , 1997, Biochemistry.

[16]  R. W. Davis,et al.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. S. Johnson,et al.  An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.

[18]  J. Barker,et al.  Large-scale temporal gene expression mapping of central nervous system development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Kavanagh,et al.  Human Signaling Protein 14-3-3ζ Interacts With Platelet Glycoprotein Ib Subunits Ibα and Ibβ , 1998 .

[20]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Turck,et al.  A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Favre,et al.  Inhibition of human tumor cell growth In vitro and In vivo by a specific inhibitor of human farnesyltransferase: BIM‐46068 , 1999, International journal of cancer.

[23]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[24]  W. Powell,et al.  Suppression of prostate carcinoma cell invasion by expression of antisense L-plastin gene. , 1999, The American journal of pathology.

[25]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Saraste,et al.  FEBS Lett , 2000 .

[27]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.